142 related articles for article (PubMed ID: 23726839)
1. Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance.
Krzystek-Korpacka M; Diakowska D; Kapturkiewicz B; Bębenek M; Gamian A
Cancer Lett; 2013 Aug; 337(1):107-14. PubMed ID: 23726839
[TBL] [Abstract][Full Text] [Related]
2. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
3. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.
Crucitti A; Corbi M; Tomaiuolo PM; Fanali C; Mazzari A; Lucchetti D; Migaldi M; Sgambato A
Cancer Biol Ther; 2015; 16(5):671-7. PubMed ID: 25875151
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.
Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA
World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702
[TBL] [Abstract][Full Text] [Related]
6. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic wounds of various etiology on systemic profiles of key inflammatory cytokines, chemokines and growth factors, and their interplay.
Krzystek-Korpacka M; Kędzior K; Masłowski L; Mierzchała M; Bednarz-Misa I; Bronowicka-Szydełko A; Kubiak J; Gacka M; Płaczkowska S; Gamian A
Adv Clin Exp Med; 2019 Oct; 28(10):1301-1309. PubMed ID: 31430066
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
9. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
Johdi NA; Mazlan L; Sagap I; Jamal R
Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
[TBL] [Abstract][Full Text] [Related]
10. Significant and Conflicting Correlation of IL-9 With
Niccolai E; Russo E; Baldi S; Ricci F; Nannini G; Pedone M; Stingo FC; Taddei A; Ringressi MN; Bechi P; Mengoni A; Fani R; Bacci G; Fagorzi C; Chiellini C; Prisco D; Ramazzotti M; Amedei A
Front Immunol; 2020; 11():573158. PubMed ID: 33488574
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
12. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
[TBL] [Abstract][Full Text] [Related]
13. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
14. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
15. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
[TBL] [Abstract][Full Text] [Related]
16. Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon.
Krzystek-Korpacka M; Zawadzki M; Neubauer K; Bednarz-Misa I; Górska S; Wiśniewski J; Witkiewicz W; Gamian A
Cancer Immunol Immunother; 2017 Feb; 66(2):171-179. PubMed ID: 27866242
[TBL] [Abstract][Full Text] [Related]
17. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease.
Førland DT; Johnson E; Saetre L; Lyberg T; Lygren I; Hetland G
Scand J Immunol; 2011 Jan; 73(1):66-75. PubMed ID: 21129005
[TBL] [Abstract][Full Text] [Related]
18. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
20. [The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis].
Avdeev AS; Novikov AA; Aleksandrova EN; Panasiuk EIu; Nasonov EL
Klin Med (Mosk); 2014; 92(1):28-34. PubMed ID: 25265656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
